logo

For the Inventor, By the Inventor

Potomac, MD, United States of America

Mario H Skiadopoulos

This inventor holds 14 USPTO granted patents and 4 published patent applications and 5 EPO patents, primarily in Viral Vaccine Development. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America. Active years: 2007-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mario H Skiadopoulos. Retrieved from https://idiyas.com/inventor/mario-h-skiadopoulos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 85.7

 

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 111(Granted Patents)


Company Filing History:

goldMedal12 out of 3,705 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
silverMedal2 out of 255 
 
The United States of America
 patents

Years Active: 2007-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Parainfluenza Virus
Vaccine Development
Recombinant Viruses
Immunogenic Compositions
Chimeric Viruses
Human Pathogens
Live-Attenuated Vaccines
Viral Vectors
14 patents (USPTO):Explore Patents
1. 9034343 - Attenuated human parainfluenza virus, methods and uses thereof (2015-05-19),
2. 8367074 - Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens (2013-02-05),
3. 7951383 - Attenuated parainfluenza virus (PIV) vaccines (2011-05-31),
4. 7919301 - Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens (2011-04-05),
5. 7820181 - Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens (2010-10-26),
6. 7704509 - Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens (2010-04-27),
7. 7704491 - Recombinant human metapneumovirus and its use (2010-04-27),
8. 7632508 - Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines (2009-12-15),
9. 7622123 - Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines (2009-11-24),
10. 7314631 - Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV) (2008-01-01),
11. 7250171 - Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein (2007-07-31),
12. 7208161 - Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences (2007-04-24),
13. 7201907 - Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines (2007-04-10),
14. 7192593 - Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens (2007-03-20),
Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…